Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/ct2/show/NCT02022930
Registration number
NCT02022930
Ethics application status
Date submitted
23/12/2013
Date registered
30/12/2013
Date last updated
25/08/2016
Titles & IDs
Public title
Hydros and Hydros-TA Joint Therapy for Pain Associated With Knee Osteoarthritis
Query!
Scientific title
A Multi-center, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Hydros and Hydros-TA Joint Therapies for Management of Pain Associated With Osteoarthritis in the Knee
Query!
Secondary ID [1]
0
0
COR1.1
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Osteoarthritis of the Knee
0
0
Query!
Condition category
Condition code
Musculoskeletal
0
0
0
0
Query!
Osteoarthritis
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Treatment: Devices - Hydros
Treatment: Devices - Hydros-TA
Treatment: Drugs - Triamcinolone Acetonide
Experimental: Hydros - Hydros Joint Therapy
Experimental: Hydros-TA - Hydros-TA Joint Therapy
Active Comparator: Triamcinolone acetonide - Triamcinolone acetonide
Treatment: Devices: Hydros
Treatment: Devices: Hydros-TA
Treatment: Drugs: Triamcinolone Acetonide
Query!
Intervention code [1]
0
0
Treatment: Devices
Query!
Intervention code [2]
0
0
Treatment: Drugs
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Primary outcome [1]
0
0
Change from baseline in the WOMAC A subscale score for the treatment knee.
Query!
Assessment method [1]
0
0
Query!
Timepoint [1]
0
0
2 weeks and 26 weeks
Query!
Secondary outcome [1]
0
0
Strict positive responders to treatment for symptomatic primary osteoarthritis of the knee
Query!
Assessment method [1]
0
0
Query!
Timepoint [1]
0
0
26 weeks
Query!
Eligibility
Key inclusion criteria
- Have radiographic evidence within the prior 6 months, as shown in the radiology
reports, of OA grade 2 or 3 using Kellgren-Lawrence Grading for OA.
- Symptoms in the index knee for at least 12 months.
- Fully ambulatory Subject (ability to perform a 15 meters walk test).
- Male and female Subjects 40 through 85 years of age.
Query!
Minimum age
40
Years
Query!
Query!
Maximum age
85
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
- BMI >40 kg
- Secondary OA (acute knee injury, rheumatoid arthritis, gout, history of joint
infection, osteonecrosis, chronic fibromyalgia) or other chronic autoimmune disease.
- Intra articular steroid therapy in last 3 months
- Intra articular viscosupplementation in last 6 months
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
The people receiving the treatment/s
The people administering the treatment/s
The people assessing the outcomes
The people analysing the results/data
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Phase 3
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Completed
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
1/01/2014
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
1/06/2016
Query!
Sample size
Target
510
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
NSW
Query!
Recruitment hospital [1]
0
0
- St.Leonards
Query!
Recruitment postcode(s) [1]
0
0
- St.Leonards
Query!
Recruitment outside Australia
Country [1]
0
0
Canada
Query!
State/province [1]
0
0
Ontario
Query!
Country [2]
0
0
Canada
Query!
State/province [2]
0
0
Oshawa
Query!
Country [3]
0
0
Canada
Query!
State/province [3]
0
0
Quebec City
Query!
Country [4]
0
0
Netherlands Antilles
Query!
State/province [4]
0
0
Curacao
Query!
Funding & Sponsors
Primary sponsor type
Commercial sector/Industry
Query!
Name
Carbylan Therapeutics, Inc.
Query!
Address
Query!
Country
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
The purpose of this study is to evaluate the safety and efficacy of Hydros-TA Joint Therapy
for relief of pain due to OA of the knee. Hydros-TA is designed to provide fast acting and
long lasting pain relief for up to six months with a single IA injection.
Query!
Trial website
https://clinicaltrials.gov/ct2/show/NCT02022930
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for scientific queries
Summary Results
For IPD and results data, please see
https://clinicaltrials.gov/ct2/show/NCT02022930
Download to PDF